Because ZFP36/TTP is deficient in abundance and activity-in cancer cells, including invasive ductal breast cancer, over-expression of ERBB2-positive genes is further augmented by prolonged mRNA stability and increased translation. This evidence concerns the gene ZFP36 and cancer.